- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03445923
Can Time-lapse Parameters be Used to Predict Pregnancy of Human Embryos?
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The aim is to study if algorithm calculated from time-lapse photography of human embryos per se can enhance the prediction of the embryo´s reproductive potential compared to embryo morphology alone.
METHODS AND MATERIAL IVF procedure Oocytes retrieved 36±1h after hCG administration will be fertilized by either standard insemination or ICSI. The morning after oocyte retrieval (day 1) zygotes will be placed into embryo time-lapse slides for culture up to the day of transfer (day 5). During the culture time, embryos will be kept in commercially available culture media and will not be removed from the time-lapse incubator until day of transfer. Embryos interact with the media and will be allowed to develop the blastocyst stage (5-6 days culture) at which time selection for transfer will be made. During the in vitro culture a single image captured in the time-lapse incubator will be used to routinely morphologically grade embryos, according to the Istanbul consensus. On day 5, developing embryos will be assessed (according to study vs. control group criteria) to select the embryo for transfer into the patient. Supernumerous GQE will be cryopreserved for future use.
Time-lapse photography All embryos will be placed in wells of time-lapse culture dishes (Embryoscope) according to the instructions of the manufacturer. Embryos in both groups will be cultured to the blastocyst stage without any media change. The time-lapse system is comprised of a desktop incubator that controls it´s environment (pH, CO2 and O2) as well as taking pictures in up to 11 focal planes for the whole duration of the culture periods.
Morphological scoring Embryo morphology will be scored according to the Gardner score and then translated to the Istanbul consensus system if needed for publication.
To assure that all embryologists annotate the embryo development correctly as well as score the blastocysts in the same way, a validation process will be performed before the onset of the study. The standardization will be accomplished through a process where the embryologists will score 20 blastocysts at day 5-development stage, which will be provided on a CD, imitating the procedure will be performed routinely in the laboratory. The embryologists will have to be approved in order to be allowed to score embryos in the study.
Embryo evaluation (both groups). Embryos will be cultured in the Embryoscope time-lapse system until day 5. If two or more blastocyst of good quality (GQB), i.e. fulfilling a minimum morphological criteria of 3BB or better, develop, a preliminary decision is made on which embryo to select for transfer. Thereafter the couple is randomized into either the control or the time-lapse group.
Decision making in the time-lapse group If the couple is randomized into the time-lapse group all embryos that have reached the blastocyst stage will be annotated. The blastocyst with the highest KID (day 5) score will be chosen for transfer. To ensure a reliable KID scores can be attained the morphological events; time to 2, 3, 4, and 5 cells, time to start of blastulation (tSB), and TE scores must be evaluated.
Decision making in the control group If the couple are randomized to the control group, the preliminary embryo selection decision will be maintained.
Study monitoring. A Data Study Monitoring Board (DSMB) Group will be assigned and have the task of conducting both safety checks and an interim analysis (planned when ca 50% of the patients have been recruited).
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Reykjavík, Iceland
- Livio Reykjavik
-
-
-
-
-
Oslo, Norway
- Livio Oslo
-
-
-
-
-
Falun, Sweden
- Livio Falun
-
Gothenburg, Sweden
- Fertilitetscentrum Livio Göteborg
-
Gothenburg, Sweden
- Sahlgrenska Universitetssjukhuset
-
Malmö, Sweden
- Livio Malmö
-
Stockholm, Sweden
- Karolinska Universtetssjukhuset
-
Stockholm, Sweden
- Livio Gärdet
-
Stockholm, Sweden
- Livio Kungsholmen
-
Stockholm, Sweden
- Sophiahemmet
-
Umeå, Sweden
- Livio Umeå
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Couples undergoing IVF or ICSI (intracytoplasmic sperm injection) that do not meet the exclusion criteria.
- The couple shall receive and sign written information about the study.
- On day 5, before the randomization the couple must have at least 2 transferrable blastocysts in order to be included in the study.
Exclusion Criteria:
- If double embryo transfer, for any reason, is planned.
- Prior participation in the study.
- Pre-implantation genetic diagnosis (PGD) treatment.
- Embryo transfer on another day than day 5.
- Oocyte cryopreservation.
- Planned total freeze of embryos for any reason (cancer, OHSS etc.)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Morphology
Embryos for transfer will be selected based on standard morphological evaluation.
|
|
|
Active Comparator: TLM
Embryos for transfer will be selected base on standard morphological evaluation and information from time-lapse monitoring.
|
The unique information that is obtainable from taking Pictures each 10 minutes throughout the development of the embryos will be used in the form of a special score (KID score).
The score is comprised out of several key developmental parameters.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Ongoing pregnancy (week 6-7)
Time Frame: Patient is assessed 6-7 weeks after embryo transfer
|
A confirmed pregnancy by ultrasound in the 6-7th week of gestation.
|
Patient is assessed 6-7 weeks after embryo transfer
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Positive pregnancy tests, 18 days after embryo transfer.
Time Frame: Patient is assessed 2 weeks after embryo transfer by taking a pregancy test
|
A pregnancy test is taken (Urine).
|
Patient is assessed 2 weeks after embryo transfer by taking a pregancy test
|
|
Early pregnancy loss (positive pregnancy test but no gestational sac observed at sonography)
Time Frame: Same time frame as for the primary outcome i.e. 6-7 weeks.
|
This is the loss of pregnancy between positive pregnancy test (2 weeks) and ultrasound (6-7 weeks)
|
Same time frame as for the primary outcome i.e. 6-7 weeks.
|
|
Correlation between the preliminary decisions of embryo fate based only on morphology and the final decision made by time-lapse
Time Frame: Can be made on the day of transfer (1 hour between primary and seconday decision).
|
In the time-lapse Group we plan to compare the decision made based solely on morphology (Before the KID score is made) and after the KID score has been applied.
|
Can be made on the day of transfer (1 hour between primary and seconday decision).
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 954-17
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Infertility
-
Assuta Hospital SystemsMaccabi Healthcare Services, IsraelCompletedInfertility, Female Infertility, Male InfertilityIsrael
-
Radboud University Medical CenterZonMw: The Netherlands Organisation for Health Research and DevelopmentCompletedPregnancy | Male Infertility | Female InfertilityNetherlands
-
Sapientiae InstituteTerminated
-
Esraa Gamal AhmedAin Shams Maternity HospitalUnknownUnexplained Female Infertility
-
Gazi UniversityCompletedMale Infertility | Unexplained Infertility
-
King's College LondonNot yet recruitingInfertility | Infertility, Female | Infertility Unexplained | Infertility of Tubal Origin
-
Wake Forest University Health SciencesWithdrawnUterine Diseases | Endometriosis | Infertility Unexplained | Endometrial Diseases | Infertility; Female, NonimplantationUnited States
-
University of WashingtonEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedMale Infertility, AzoospermiaUnited States
-
Pacific Fertility CenterTerminatedPrimary Female Infertility | Secondary Female Infertility
-
Yuzuncu Yil UniversityCompletedUnexplained Infertility | Female Infertility | Anovulatory InfertilityTurkey (Türkiye)
Clinical Trials on Time lapse monitoring (KID Score)
-
Kaali Institute IVF CenterForgacs Intezet Kft.TerminatedClinical Pregnancy After Single Embryo TransferHungary
-
Dr. Murat ÇetinkayaTerminated
-
Li-jun DingUnknown
-
Shanghai First Maternity and Infant HospitalUnknown
-
University Hospital, Clermont-FerrandService Biologie de la reproduction-CECOSUnknownSpermatic Parameters | Embryonic KineticsFrance
-
ProcreatecSociedad Espanola FertilidadUnknownEmbryo ImplantationSpain
-
Regionshospitalet Viborg, SkiveActive, not recruitingIn Vitro Fertilization | Assisted Reproductive TechniquesDenmark
-
Shaare Zedek Medical CenterUnknownInfertility | Genetic DiseasesIsrael
-
University Hospital, BordeauxProgramme Hospitalier de Recherche Clinique Inter-Régionale (PHRC-I)Active, not recruiting